Banyan Biomarkers Initiates TBI Clinical Trial to Evaluate Biomarkers
Banyan Biomarkers will be initiating a multi-center, international clinical trial to prove the effectiveness of the company’s protein biomarkers and their ability to detect traumatic brain injury in 2008. The clinical trial will be held at the R. Adams Cowley Shock Trauma Center at the University of Maryland Medical Center, Orlando Regional Medical Center in Orlando, Florida, University of California Davis Health System in Sacramento, California, University Pecs and University of Szeged in Hungary and the University of Padova in Italy. Banyan has developed a panel of biomarkers that will be tested in the blood and cerebrospinal fluid from over 200 severe traumatic brain injury patients. If the study proves effective, the results will be submitted to the FDA for another trial. This clinical study will be the first effort to systematically evaluate a biomarker in brain-injured patients. The U.S Department of Defense, Congress and the National Institutes of Health have helped financially support this endeavor.
